Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Titel:
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
Auteur:
Wirsching, H.-G. Tabatabai, G. Roelcke, U. Hottinger, A.F. Jörger, F. Schmid, A. Plasswilm, L. Schrimpf, D. Mancao, C. Capper, D. Conen, K. Hundsberger, T. Caparrotti, F. von Moos, R. Riklin, C. Felsberg, J. Roth, P. Jones, D.T.W. Pfister, S. Rushing, E.J. Abrey, L. Reifenberger, G. Held, L. von Deimling, A. Ochsenbein, A. Weller, M.